Cystic Fibrosis : Heterogeneity and Personalized Treatment (Record no. 42232)

MARC details
000 -LEADER
fixed length control field 02009naaaa2200337uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/67589
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220219203631.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number intechopen.77691
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789841466
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789841459
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781838809683
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/intechopen.77691
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJK
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wat, Dennis
Relationship edt
245 10 - TITLE STATEMENT
Title Cystic Fibrosis : Heterogeneity and Personalized Treatment
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (136 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. Cystic Fibrosis - Heterogeneity and Personalized Treatment provides the latest research and clinical evidence for clinicians, scientists and researchers involved in the care of patients with cystic fibrosis (CF). This book outlines the burden of the CF microbiome, utilisation of CF registries to impact future care, the sequelae of hepatobiliary complication, the use of upcoming technologies to provide patient-centred care, and provides an overview of cystic fibrosis transmembrane regulator (CFTR) modulators. Looking after patients with CF is highly rewarding, allowing those of us to combine our dedication and problem-solving skills to create a personalized approach. This book is invaluable for those involved in the care of CF patients.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by/3.0/
Source of term cc
-- https://creativecommons.org/licenses/by/3.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dermatology
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Respiratory medicine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nazareth, Dilip
Relationship edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wat, Dennis
Relationship oth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nazareth, Dilip
Relationship oth
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mts.intechopen.com/storage/books/7872/authors_book/authors_book.pdf">https://mts.intechopen.com/storage/books/7872/authors_book/authors_book.pdf</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/67589">https://directory.doabooks.org/handle/20.500.12854/67589</a>
Access status 0
Public note DOAB: description of the publication

No items available.